Journal of Cancer Therapy

Volume 4, Issue 6 (July 2013)

ISSN Print: 2151-1934   ISSN Online: 2151-1942

Google-based Impact Factor: 0.30  Citations  h5-index & Ranking

Assessment of the Roles of Cathepsins B, H and L in the Progression of Colorectal Cancer

HTML  Download Download as PDF (Size: 166KB)  PP. 1-7  
DOI: 10.4236/jct.2013.46A2001    13,261 Downloads   39,374 Views  Citations

ABSTRACT

Cysteine cathepsins are important regulators and signaling molecules of an unimaginable number of biological processes, while they concurrently play an essential role in cancer progression, invasion and metastasis. The purposes of our study were to: a) compare the expression levels of cathepsins B, H and L in the supernatants of colon cancer tissues from 74 patients versus the corresponding enzymic expressions of supernatants in the adjacent normal colorectal tissues; and b) correlate our results to the grade of the malignancy by using an enzyme-linked immunosorbent assay (ELISA). The findings indicated that cathepsins B, H and L of all malignant tissues exhibited significantly higher expression levels than their corresponding controls. Furthermore, cathepsin B expression levels doubled in all tumor samples and this increase remained quite steady with tumor stage advancement, in contrast to cathepsin H expression which rose significantly as malignancy progressed. Specifically, cathepsin H concentration was higher than the corresponding control: 155% in B1 stage and 204.44% in D stage. Among the three investigated proteases, cathepsin L has shown the highest increase, which in D stage stood 261.03% higher than the corresponding control. The results at hand suggested that cysteine protease H and L expression levels could be of critical value in the diagnosis and progression of colon cancer.

Share and Cite:

A. Doxakis, A. Maria, P. Savvas and I. Zafiroula, "Assessment of the Roles of Cathepsins B, H and L in the Progression of Colorectal Cancer," Journal of Cancer Therapy, Vol. 4 No. 6B, 2013, pp. 1-7. doi: 10.4236/jct.2013.46A2001.

Cited by

[1] Evaluation of Serum Cathepsin B as a Biomarker in Colorectal Cancer Patients
Evaluation, 2021
[2] Expression and Clinical Implications of Cysteine Cathepsins in Gallbladder Carcinoma
2019
[3] Beta-defensin derived cationic antimicrobial peptides with potent killing activity against gram negative and gram positive bacteria
2018
[4] Avian β-defensins as antimicrobial and immunomodulatory agents
2018
[5] Extracellular matrix and colorectal cancer: how surrounding microenvironment affects cancer cell behavior?
Journal of cellular physiology, 2017
[6] PEG-peptide drug carrier systems with enzymatic degradation units
2017
[7] Assessment the Immunohistochemical Expression of Cathepsin D in Iraqi Patients with Colorectal Carcinoma
Iraqi Journal of Science, 2015
[8] Cathepsin L targeting in cancer treatment
Pharmacology & therapeutics, 2015
[9] Efficient utilization of 6-aminouracil to synthesize fused and related heterocyclic compounds and their evaluation as prostate cytotoxic agents with cathepsin B …
2014
[10] Impact of the Enhanced Permeability and Retention (EPR) Effect and Cathepsins Levels on the Activity of Polymer-Drug Conjugates
Polymers, 2014
[11] Efficient Utilization of 6-Aminouracil to Synthesize Fused and Related Heterocyclic Compounds and Their Evaluation as Prostate Cytotoxic Agents with Cathepsin B Inhibition
Open Journal of Medicinal Chemistry, 2014

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.